Company Filing History:
Years Active: 2020-2022
Title: Trine Soerensen: Innovator in Cellobiohydrolase Variants
Introduction
Trine Soerensen, an accomplished inventor based in Copenhagen, Denmark, has significantly contributed to the field of biotechnology through her innovative work. With a focus on cellobiohydrolase variants, she holds two patents that showcase her expertise and commitment to advancing scientific knowledge.
Latest Patents
Trine's latest patents include "Polypeptides having cellobiohydrolase activity and polynucleotides encoding same" and "Cellobiohydrolase variants and polynucleotides encoding same." These inventions pertain to the development of cellobiohydrolase variants and carbohydrate binding module variants. The patents detail polynucleotides that encode these variants, along with nucleic acid constructs, vectors, and host cells that utilize the polynucleotides. Additionally, the methods of using these variants are encompassed, highlighting Trine's significant contributions to the field.
Career Highlights
Trine Soerensen is currently affiliated with Novozymes A/S, a leading biotechnology company known for its research in enzymes and microorganisms. Her roles and contributions at the company have emphasized her pivotal position within the industry as a driving force behind groundbreaking inventions.
Collaborations
Throughout her career, Trine has collaborated with several notable colleagues, including Peter Westh and Kim Borch. These partnerships have enhanced her research and contributed to the successful development of her patents, showcasing the importance of teamwork in achieving scientific advancements.
Conclusion
Trine Soerensen's innovative spirit and dedication to research have led to significant advancements in the understanding of cellobiohydrolase variants. Her patents reflect not only her personal accomplishments but also her commitment to furthering the biotechnology sector, position her as an influential figure in the industry.